Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-09-06

Clinical Trial Update: Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating bevacizumab in combination with chemotherapy for metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avastin (bevacizumab)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN